| pubmed-article:17145823 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17145823 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:17145823 | lifeskim:mentions | umls-concept:C0023467 | lld:lifeskim |
| pubmed-article:17145823 | lifeskim:mentions | umls-concept:C0242643 | lld:lifeskim |
| pubmed-article:17145823 | lifeskim:mentions | umls-concept:C2348499 | lld:lifeskim |
| pubmed-article:17145823 | pubmed:issue | 23 | lld:pubmed |
| pubmed-article:17145823 | pubmed:dateCreated | 2006-12-5 | lld:pubmed |
| pubmed-article:17145823 | pubmed:abstractText | Patients with adult acute myeloid leukemia (AML) with intermediate cytogenetics remain a heterogeneous group with highly variable individual prognoses. New molecular markers could help to refine cytogenetic stratification. | lld:pubmed |
| pubmed-article:17145823 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17145823 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17145823 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17145823 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17145823 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17145823 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17145823 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17145823 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:17145823 | pubmed:issn | 1078-0432 | lld:pubmed |
| pubmed-article:17145823 | pubmed:author | pubmed-author:TeyssandierII | lld:pubmed |
| pubmed-article:17145823 | pubmed:author | pubmed-author:CasadevallNic... | lld:pubmed |
| pubmed-article:17145823 | pubmed:author | pubmed-author:LegrandOllivi... | lld:pubmed |
| pubmed-article:17145823 | pubmed:author | pubmed-author:MarieJean-Pie... | lld:pubmed |
| pubmed-article:17145823 | pubmed:author | pubmed-author:FaussatAnne-M... | lld:pubmed |
| pubmed-article:17145823 | pubmed:author | pubmed-author:PerrotJean-Yv... | lld:pubmed |
| pubmed-article:17145823 | pubmed:author | pubmed-author:TangRuopingR | lld:pubmed |
| pubmed-article:17145823 | pubmed:author | pubmed-author:MarzacChristo... | lld:pubmed |
| pubmed-article:17145823 | pubmed:author | pubmed-author:CalendiniOrs'... | lld:pubmed |
| pubmed-article:17145823 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17145823 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:17145823 | pubmed:volume | 12 | lld:pubmed |
| pubmed-article:17145823 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17145823 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17145823 | pubmed:pagination | 7018-24 | lld:pubmed |
| pubmed-article:17145823 | pubmed:dateRevised | 2009-11-19 | lld:pubmed |
| pubmed-article:17145823 | pubmed:meshHeading | pubmed-meshheading:17145823... | lld:pubmed |
| pubmed-article:17145823 | pubmed:meshHeading | pubmed-meshheading:17145823... | lld:pubmed |
| pubmed-article:17145823 | pubmed:meshHeading | pubmed-meshheading:17145823... | lld:pubmed |
| pubmed-article:17145823 | pubmed:meshHeading | pubmed-meshheading:17145823... | lld:pubmed |
| pubmed-article:17145823 | pubmed:meshHeading | pubmed-meshheading:17145823... | lld:pubmed |
| pubmed-article:17145823 | pubmed:meshHeading | pubmed-meshheading:17145823... | lld:pubmed |
| pubmed-article:17145823 | pubmed:meshHeading | pubmed-meshheading:17145823... | lld:pubmed |
| pubmed-article:17145823 | pubmed:meshHeading | pubmed-meshheading:17145823... | lld:pubmed |
| pubmed-article:17145823 | pubmed:meshHeading | pubmed-meshheading:17145823... | lld:pubmed |
| pubmed-article:17145823 | pubmed:meshHeading | pubmed-meshheading:17145823... | lld:pubmed |
| pubmed-article:17145823 | pubmed:meshHeading | pubmed-meshheading:17145823... | lld:pubmed |
| pubmed-article:17145823 | pubmed:meshHeading | pubmed-meshheading:17145823... | lld:pubmed |
| pubmed-article:17145823 | pubmed:meshHeading | pubmed-meshheading:17145823... | lld:pubmed |
| pubmed-article:17145823 | pubmed:meshHeading | pubmed-meshheading:17145823... | lld:pubmed |
| pubmed-article:17145823 | pubmed:meshHeading | pubmed-meshheading:17145823... | lld:pubmed |
| pubmed-article:17145823 | pubmed:meshHeading | pubmed-meshheading:17145823... | lld:pubmed |
| pubmed-article:17145823 | pubmed:meshHeading | pubmed-meshheading:17145823... | lld:pubmed |
| pubmed-article:17145823 | pubmed:meshHeading | pubmed-meshheading:17145823... | lld:pubmed |
| pubmed-article:17145823 | pubmed:meshHeading | pubmed-meshheading:17145823... | lld:pubmed |
| pubmed-article:17145823 | pubmed:meshHeading | pubmed-meshheading:17145823... | lld:pubmed |
| pubmed-article:17145823 | pubmed:year | 2006 | lld:pubmed |
| pubmed-article:17145823 | pubmed:articleTitle | Flt3 internal tandem duplication and P-glycoprotein functionality in 171 patients with acute myeloid leukemia. | lld:pubmed |
| pubmed-article:17145823 | pubmed:affiliation | Université Pierre et Marie Curie-Paris 6, UMRS 736, Les Cordeliers, INSERM, Paris F-75006, France. | lld:pubmed |
| pubmed-article:17145823 | pubmed:publicationType | Journal Article | lld:pubmed |
